Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export

Lei, Peng, Ayton, Scott, Finkelstein, David I, Spoerri, Loredana, Ciccotosto, Giuseppe D, Wright, David K, Wong, Bruce X W, Adlard, Paul A +9 more·2012·Nature Medicine
DOI 10.1038/nm.2613

Cited by (596)

Items 401–500 of 596

  1. Experimental Models of Cognitive Impairment for Use in Parkinson’s Disease Research: The Distance Between Reality and Ideal
    Yaohua Fan, Jiajun Han, Lijun Zhao, Chunxiao Wu, Peipei Wu, Zifeng Huang, Xiaoqian Hao, Yichun Ji, Dongfeng Chen, Meiling Zhu · 2021 · Frontiers in Aging Neuroscience
  2. Implications of Tau Dysregulation in Huntington’s Disease and Potential for New Therapeutics
    Isaline Mees, Rebecca M. Nisbet, Anthony John Hannan, Thibault Renoir · 2023 · Journal of Huntington s Disease
  3. Ferroptosis—A Shared Mechanism for Parkinson’s Disease and Type 2 Diabetes
    Carmen Duţă, Corina Muscurel, Carmen Beatrice Dogaru, Irina Anna-Maria Stoian · 2024 · International Journal of Molecular Sciences
  4. The role of ferritinophagy and ferroptosis in Alzheimer’s disease
    Ziwen Chen, Nan Zheng, Fuwei Wang, Qiong Zhou, Zihao Chen, Lihua Xie, Qiang Sun, Li Li, Baohong Li · 2024 · Brain Research
  5. Iron(ing) out parkinsonisms: The interplay of proteinopathy and ferroptosis in Parkinson's disease and tau-related parkinsonisms
    Maria João da Costa Caiado, Amalia M. Dolga, Wilfred F.A. den Dunnen · 2024 · Redox Biology
  6. Changes in cortical protein markers of iron transport with gender, major depressive disorder and suicide
    Brian Dean, Andrew Tsatsanis, Linh Q. Lam, Elizabeth Scarr, James A. Duce · 2018 · The World Journal of Biological Psychiatry
  7. The genetic ablation of tau improves long-term, but not short-term, functional outcomes after experimental traumatic brain injury in mice
    Xin Lin Tan, Ping Zheng, David K. Wright, Mujun Sun, Rhys D. Brady, Shijie Liu, Stuart J. McDonald, Richelle Mychasiuk, Sitare Cenap, Nigel C. Jones et al. · 2019 · Brain Injury
  8. Inducible Expression of a Truncated Form of Tau in Oligodendrocytes Elicits Gait Abnormalities and a Decrease in Myelin: Implications for Selective CNS Degenerative Diseases
    Patrizia LoPresti · 2015 · Neurochemical Research
  9. ATH434 Rescues Pre-motor Hyposmia in a Mouse Model of Parkinsonism
    Leah C. Beauchamp, Xiang M. Liu, Laura J. Vella, Paul Anthony Adlard, Ashley Ian Bush, David Isaac Finkelstein, Kevin Jeffrey Barnham · 2022 · Neurotherapeutics
  10. Overexpression of FSP1 Ameliorates ferroptosis via PI3K/ AKT /GSK3β pathway in PC12 cells with Oxygen-Glucose Deprivation/Reoxygenation
    Yonghui Wu, Haoyu Shi, Jie Zheng, Yang Yang, Xuejiao Lei, Xiao Qian, Jie Zhu · 2023 · Heliyon
  11. Cell density impacts the susceptibility to ferroptosis by modulating IRP1 ‐mediated iron homeostasis
    Hong-Fa Yan, Qing‐zhang Tuo, Peng Lei · 2024 · Journal of Neurochemistry
  12. Ferroptosis: A new strategy for targeting Alzheimer’s disease
    Rong Rong Qiang, Yang Xiang, Lei Zhang, Xin Yue Bai, Die Zhang, Yang Jing Li, Yan Ling Yang, Xiao Long Liu · 2024 · Neurochemistry International
  13. Widespread hyperphosphorylated tau in the working memory circuit early after cortical impact injury of brain (Original study)
    Zi‐Ai Zhao, Ya‐Lei Ning, Ping Li, Nan Yang, Yan Peng, Ren‐Ping Xiong, Yan Zhao, Dong Liu, Xujia Zeng, Jiang‐Fan Chen et al. · 2017 · Behavioural Brain Research
  14. Conformation-based assay of tau protein aggregation
    Yann Fichou, Neil A. Eschmann, Timothy J. Keller, Songi Han · 2017 · Methods in cell biology
  15. Microtubule-Tau Interaction as a Therapeutic Target for Alzheimer’s Disease
    Yanina Ivashko‐Pachima, Liu-yao Zhou, Peng Lei, Illana Gozes · 2016 · Journal of Molecular Neuroscience
  16. Pros and cons of narrow- versus wide-compartment rotarod apparatus: An experimental study in mice
    Sachiko P. Keane, Kathryn K. Chadman, Andres R. Gomez, Wen Hui Hu · 2024 · Behavioural Brain Research
  17. DNALI1 Promotes Neurodegeneration after Traumatic Brain Injury via Inhibition of Autophagosome‐Lysosome Fusion
    Xulong Ding, Shuqiang Cao, Qing Wang, Bin Du, Kefeng Lu, Shiqian Qi, Ying Cheng, Qing‐zhang Tuo, Weibo Liang, Peng Lei · 2024 · Advanced Science
  18. Tau mis-splicing correlates with motor impairments and striatal dysfunction in a model of tauopathy
    Ana Damianich, Carolina Lucía Facal, Javier Andrés Muñiz, Camilo J. Mininni, Mariano Soiza‐Reilly, Magdalena Ponce de León, Leandro Urrutia, Germán Falasco, Juan Esteban Ferrario, María Elena Avale · 2021 · Brain
  19. Antioxidant dihydrolipolic acid protects against in vitro aluminum‐induced toxicity
    Sonia Sanajou, Anıl Yirün, Göksun Demirel, Deniz Arca Çakır, Gönül Şahin, Pınar Erkekoğlu, Terken Baydar · 2023 · Journal of Applied Toxicology
  20. Whole-exome sequencing identifies protein-coding variants associated with brain iron in 29,828 individuals
    Weikang Gong, Yan Hong Huang Fu, Bang‐Sheng Wu, Jingnan Du, Liu Yang, Ya-Ru Zhang, Shi-Dong Chen, Jujiao Kang, Ying Qing Mao, Qiang Dong et al. · 2024 · Nature Communications
  21. Cortical phase changes measured using 7‐T MRI in subjects with subjective cognitive impairment, and their association with cognitive function
    Sanneke van Rooden, Mathijs Buijs, Marjolein E. van Vliet, Maarten J. Versluis, ANDREW G. WEBB, Ania M. Oleksik, Lotte van de Wiel, Huub A. M. Middelkoop, Gerard J. Blauw, Annelies W. E. Weverling‐Rynsburger et al. · 2014 · NMR in Biomedicine
  22. Diagnostics and Treatments of Iron-Related CNS Diseases
    Huan Xiong, Qing‐zhang Tuo, Yujie Guo, Peng Lei · 2019 · Advances in experimental medicine and biology
  23. Targeting Mitochondrial Metal Dyshomeostasis for the Treatment of Neurodegeneration
    Jeffrey R. Liddell · 2015 · Neurodegenerative Disease Management
  24. Worms, Fat, and Death: Caenorhabditis elegans Lipid Metabolites Regulate Cell Death
    Marcos A. Perez, Jennifer L. Watts · 2021 · Metabolites
  25. Humanized Tau Mice with Regionalized Amyloid Exhibit Behavioral Deficits but No Pathological Interaction
    Michael J. Yetman, Stephanie Fowler, Joanna L. Jankowsky · 2016 · PLoS ONE
  26. Microtubule Organization and Microtubule-Associated Proteins (MAPs)
    Elena Tortosa, Lukas C. Kapitein, Casper C. Hoogenraad · 2016 · Springer eBooks
  27. Our Working Point of View of Tau Protein
    Jesús Ávila · 2017 · Journal of Alzheimer s Disease
  28. Association of Transfusion With Risks of Dementia or Alzheimer’s Disease: A Population-Based Cohort Study
    Shih-Yi Lin, Wu‐Huei Hsu, Cheng‐Chieh Lin, Cheng‐Li Lin, Hung‐Chieh Yeh, Chia‐Hung Kao · 2019 · Frontiers in Psychiatry
  29. Therapeutic applications of chelating drugs in iron metabolic disorders of the brain and retina
    Ali Shahandeh, Bang Viet Bui, David Isaac Finkelstein, Christine T. O. Nguyen · 2020 · Journal of Neuroscience Research
  30. The Pathological Nexus and Multipronged Approaches to Mitigate Ferroptosis and Alzheimer’s Disease
    Hariharan Moorthy, Shreyasri Sain, Dikshaa Padhi, Thimmaiah Govindaraju · 2025 · Journal of Medicinal Chemistry
  31. Targeting the Gut-Brain-Ferroptosis Axis: Molecular Mechanisms and Therapeutic Potential in Alzheimer’s Disease and Epilepsy
    Mohamed N Fawzy, Mohamed K. Fathy · 2026 · Journal of Molecular Neuroscience
  32. Tau reduction attenuates autism-like features in Fmr1 knockout mice
    Zhao, Shanshan, Jiang, Xiangyu, Han, Linkun, Jiang, Yiru, Wang, Yong, Meng, Jian, Zhu, Xiang, Zhang, Xian, Luo, Hong, Zhang, Yun-wu · 2023 · Molecular Autism
  33. Amyotrophic lateral sclerosis associated disturbance of iron metabolism is blunted by swim training-role of AKT signaling pathway
    Małgorzata Hałoń, Damian Józef Flis, Hans Zischka, Banu Akdogan, Mariusz Roman Wieckowski, Jędrzej Antosiewicz, Wiesław Ziółkowski · 2024 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  34. Mapping the Research of Ferroptosis in Parkinson’s Disease from 2013 to 2023: A Scientometric Review
    Yingfan Chen, Zhenhui Wu, Shaodan Li, Qi Chen, Liang Wang, Xiaorong Qi, Chujiao Tian, Minghui Yang · 2024 · Drug Design Development and Therapy
  35. Targeting Metals in Alzheimer’s Disease: An Update
    Bin Du, Kang Chen, Weiwei Wang, Peng Lei · 2024 · Journal of Alzheimer s Disease
  36. The Underestimated Role of Iron in Frontotemporal Dementia: A Narrative Review
    Sara Ferretti, Isabella Zanella · 2024 · International Journal of Molecular Sciences
  37. The Strategies for Treating “Alzheimer’s Disease”: Insulin Signaling May Be a Feasible Target
    Guanying You, Jinyi Yao, Qiong Liu, Nan Li · 2022 · Current Issues in Molecular Biology
  38. Mechanistic approaches to understand the prion-like propagation of aggregates of the human tau protein
    Harish Kumar, Jayant B. Udgaonkar · 2019 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
  39. Rethinking IRPs/IRE system in neurodegenerative disorders: looking beyond iron metabolism.
    Zheng-Yang Yao, Lin Fu, F. Jia, Ming-Xia Bi, Q. Jiao, Xi Chen, Xi-Xun Du, Hong Jiang · 2021 · Ageing Research Reviews
  40. Pin1-catalyzed conformational regulation after phosphorylation: A distinct checkpoint in cell signaling and drug discovery
    Kun Ping Lu, Xiao Zhen Zhou · 2024 · Science Signaling
  41. The Fate of Tau Aggregates Between Clearance and Transmission
    Assel Seitkazina, Kyu Hyeon Kim, Erin Fagan, Yoonsik Sung, Yun Kyung Kim, Sungsu Lim · 2022 · Frontiers in Aging Neuroscience
  42. Ferroptosis-Regulated Cell Death as a Therapeutic Strategy for Neurodegenerative Diseases: Current Status and Future Prospects
    Jiabao Zhang, Xiuqin Jia, Qi Cao, Yi-Ting Chen, Jie Tong, Guo‐Dong Lu, Dongjie Li, Ting Han, Chunlin Zhuang, Pei Wang · 2023 · ACS Chemical Neuroscience
  43. Biometals and Alzheimer’s Disease
    Alexandra I. Mot, Peter John Crouch · 2017 · Elsevier eBooks
  44. Tau at the Crossroads between Neurotoxicity and Neuroprotection
    Sarah L. DeVos, Bradley T. Hyman · 2017 · Neuron
  45. Heavy metals toxicity on epigenetic modifications in the pathogenesis of Alzheimer's disease (AD)
    Dhivya Venkatesan, Sindduja Muthukumar, Mahalaxmi Iyer, Harysh Winster Suresh Babu, Abilash Valsala Gopalakrishnan, Mukesh Yadav, Balachandar Vellingiri · 2024 · Journal of Biochemical and Molecular Toxicology
  46. Empirical evidence for biometal dysregulation in Parkinson’s disease from a systematic review and Bradford Hill analysis
    Amr H. Abdeen, Benjamin Guy Trist, Kay L. Double · 2022 · npj Parkinson s Disease
  47. Tau modulation through AAV9 therapy augments Akt/Erk survival signalling in glaucoma mitigating the retinal degenerative phenotype
    Kanishka Pushpitha Maha Thananthirige, Nitin Chitranshi, Devaraj K. Basavarajappa, Rashi Rajput, Mojdeh Abbasi, Viswanthram Palanivel, Veer Bala Gupta, João A. Paulo, Maya Koronyo‐Hamaoui, Mehdi Mirzaei et al. · 2024 · Acta Neuropathologica Communications
  48. The toxin MPTP generates similar cognitive and locomotor deficits in hTau and tau knock-out mice
    Maud Gratuze, Nicolas Josset, Franck R. Petry, Mathieu Pflieger, Laura Eyoum Jong, Geoffrey Truchetti, Isabelle Poitras, Jacinthe Julien, François Bezeau, Françoise Morin et al. · 2019 · Brain Research
  49. [The role of ferroptosis in chronic diseases].
    Junyi Chen, Yang Xiang, Xuexian Fang, Fudi Wang, Junxia Min · 2020 · PubMed Central
  50. Dental follicle cells show potential for treating Parkinson’s disease through dopaminergic-neuronogenic differentiation
    Fei Bi, Jie Xiong, Xue Han, Chao Yang, Xinghan Li, Guoqing Chen, Weihua Guo, Weidong Tian · 2022 · Human Cell
  51. A novel approach to explore organochalcogen chemistry of tellurium based receptor for selective determination of silver ions in aqueous medium
    Aman K. K. Bhasin, Jasminder Singh, Harjit Singh, Pushap Raj, Narinder Singh, Navneet Kaur, K.K. Bhasin · 2016 · Polyhedron
  52. Monoamines and their Derivatives on GPCRs: Potential Therapy for Alzheimer’s Disease
    Eunice D. Farfán‐García, Ricardo Márquez-Gómez, Mónica Barrón‐González, Teresa Pérez‐Capistran, Martha Cecilia Rosales‐Hernández, Rodolfo Pinto‐Almazán, Marvin Antonio Soriano-Ursua · 2019 · Current Alzheimer Research
  53. Epigenetic Regulation of Ferroportin in Primary Cultures of the Rat Blood-Brain Barrier
    Steinunn Sara Helgudóttir, Lisa Greve Routhe, Annette Burkhart, Katrine Jønsson, Inge Søkilde Pedersen, Jacek Lichota, Torben Moos · 2020 · Molecular Neurobiology
  54. Axonal dispatch of iron in neuronal signaling
    Peng Lei, Scott Ayton, Ashley Ian Bush · 2019 · Nature Chemical Biology
  55. Diagnostic and therapeutic targeting of pathological tau proteins in neurodegenerative disorders
    Naruhiko Sahara, Makoto Higuchi · 2023 · FEBS Open Bio
  56. Ferroptosis and Alzheimer’s disease: a new insight into neurodegeneration
    Youfang Quan, Hongwei Liu, Minheng Zhang, Meng Li, Bo He, Ke Wang, Xuewen Huang, Shengyang Zhou, Zhongyu Han, Haixia Fan · 2026 · Frontiers in Immunology
  57. The Deficits of Insulin Signal in Alzheimer’s Disease and the Mechanisms of Vanadium Compounds in Curing AD
    Jinyi Yao, Zhijun He, Guanying You, Qiong Liu, Nan Li · 2023 · Current Issues in Molecular Biology
  58. Unraveling the tau puzzle: a review of mechanistic targets and therapeutic interventions to prevent tau pathology in Alzheimer’s disease
    Sachin V Kammula, Sulagna Tripathi, Ning Wang, Valina Lynn Dawson, Ted M. Dawson, Xiaobo Mao · 2023 · Ageing and Neurodegenerative Diseases
  59. A role for iron deficiency in dopaminergic neurodegeneration
    Yvette Y. Yien, Barry H. Paw · 2016 · Proceedings of the National Academy of Sciences
  60. Caffeine Decreases Hepcidin Expression to Alleviate Aberrant Iron Metabolism under Inflammation by Regulating the IL-6/STAT3 Pathway
    Zhongda Li, Meng-Yu Geng, Song-Rui Dou, Xuan Wang, Zi‐Han Zhang, Yan‐Zhong Chang · 2022 · Life
  61. New Beginnings in Alzheimer’s Disease: The Most Prevalent Tauopathy
    Félix Hernández, Marı́a Llorens-Martı́n, Marta Bolós, Mar Pérez, Raquel Cuadros, Noemí Pallas‐Bazarra, Juan Carlos Zabala, Jesús Ávila · 2018 · Journal of Alzheimer s Disease
  62. Diverse influences on tau aggregation and implications for disease progression
    Meaghan Van Alstyne, James Pratt, Roy Parker · 2025 · Genes & Development
  63. Retinal hyperspectral imaging in mouse models of Parkinson’s disease and healthy aging
    Paul Trlin, Jenny D. Gong, Katie K. N. Tran, Vickie H. Y. Wong, Pei Ying Lee, Anh Hoang, Da You Zhao, Leah C. Beauchamp, Jeremiah K. H. Lim, Andrew B. Metha et al. · 2024 · Scientific Reports
  64. Assessment of gastrointestinal function and enteric nervous system changes over time in the A53T mouse model of Parkinson’s disease
    Myat Noe Han, Madeleine R. Di Natale, Enie Lei, John B. Furness, David Isaac Finkelstein, Marlene M. Hao, Shanti Diwakarla, Rachel Mai McQuade · 2025 · Acta Neuropathologica Communications
  65. Amyloid Precursor Protein Haploinsufficiency Preferentially Mediates Brain Iron Accumulation in Mice Transgenic for The Huntington’s Disease Mutation
    Kiersten L. Berggren, Sonal Agrawal, Julia A. Fox, Justin R. V. Hildenbrand, Ryan Nelson, Ashley Ian Bush, Jonathan H. Fox · 2017 · Journal of Huntington s Disease
  66. Expression of tau and phosphorylated tau in the brain of normal and hemiparkinsonian rhesus macaques
    Julia C. Gambardella, Wyatt Schoephoerster, Viktoriya Bondarenko, Brian S. Yandell, Marina Elena Emborg · 2023 · The Journal of Comparative Neurology
  67. Tracing the toxic ions of an endodontic tricalcium silicate-based sealer in local tissues and body organs
    Índia Olinta de Azevedo Queiroz, Thiago Machado, Camila Carneiro Alves, Ana Maria Veiga Vasques, Marina Tolomei Sandoval Cury, Bruno Carvalho de Vasconcelos, João Eduardo Gomes‐Filho, Rodrigo Ricci Vivan, Tiago Braga, Robert Matthew Love et al. · 2021 · Journal of Trace Elements in Medicine and Biology
  68. Tau haploinsufficiency causes prenatal loss of dopaminergic neurons in the ventral tegmental area and reduction of transcription factor orthodenticle homeobox 2 expression
    Meige Zheng, Luyan Jiao, Xiaolu Tang, Xianhong Xiang, Xiaomei Wan, Yan Yan, Xingjian Li, Guofeng Zhang, Yonglin Li, Bin Jiang et al. · 2017 · The FASEB Journal
  69. Differential Effect of Acute Iron Overload on Oxidative Status and Antioxidant Content in Regions of Rat Brain
    Natacha E. Piloni, R. Macarena Reiteri, Marcelo Pablo Hernando, Claudio O. Cervino, Susana Puntarulo · 2017 · Toxicologic Pathology
  70. Tau protein: Physiological functions and multifaceted roles in neurodegenerative and psychiatric disorders
    Fei Tang, Junfen Wei, Ma-Li Wong, Peng Lei · 2025 · Genomic psychiatry :
  71. Investigational therapeutics for the treatment of progressive supranuclear palsy
    David G. Coughlin, Irene Litvan · 2022 · Expert Opinion on Investigational Drugs
  72. [Progression of gestational hypertension to preeclampsia].
    Juan Fernando Romero-Arauz, Cristina Basilisa Ortiz-Díaz, Alfredo Leaños‐Miranda, Óscar Arturo Martínez-Rodríguez · 2014 · PubMed
  73. TSEREBRALNYYE NARUSHENIYA OBMENA ZHELEZA KAK OSNOVA RAZVITIYA I PROGRESSIROVANIYA NEYRODEGENERATIVNYKH ZABOLEVANIY
    Igor Litvinenko, Красаков Игорь Вячеславович, Artem G. Trufanov · 2018 · Bulletin of the Russian Military Medical Academy
  74. Luteolin Ameliorates Methamphetamine-Induced Podocyte Pathology by Inhibiting Tau Phosphorylation in Mice
    Jiuyang Ding, Yuanhe Wang, Zhuo Wang, Shanshan Hu, Li Zhu, Cuiyun Le, Jian An Huang, Xiang Xu, Jiang Huang, Pingming Qiu · 2022 · Evidence-based Complementary and Alternative Medicine
  75. Tau Deficiency Down-Regulated Transcription Factor Orthodenticle Homeobox 2 Expression in the Dopaminergic Neurons in Ventral Tegmental Area and Caused No Obvious Motor Deficits in Mice
    Xiaolu Tang, Luyan Jiao, Meige Zheng, Yan Yan, Qi Nie, Ting Wu, Xiaomei Wan, Guofeng Zhang, Yonglin Li, Song Wu et al. · 2018 · Neuroscience
  76. Animal Models of Acquired Epilepsy and Tauopathies
    Ping Zheng, Sandy R. Shultz, Christopher M. Hovens, Terence John O'Brien · 2017 · Elsevier eBooks
  77. Crosstalk between copper, Alzheimer’s disease, and melatonin
    Deepika, Ashima Thakur, Archna Panghal, Rajesh Pundir, Charan Singh, Manoj Goyal, Ajay Gajanan Namdeo, Jayant Kumar · 2025 · BioMetals
  78. Ferroptosis in neurological diseases: moving towards therapeutic intervention
    Qing‐zhang Tuo, Ashley Ian Bush, Peng Lei · 2026 · Molecular Psychiatry
  79. Leucine‐rich repeat kinase 2 (LRRK2) inhibition upregulates microtubule‐associated protein 1B to ameliorate lysosomal dysfunction and parkinsonism
    Kang Chen, Fei Tang, Bin Du, Zhe‐Zhou Yue, Lingling Jiao, Xulong Ding, Qing‐zhang Tuo, Jie Meng, Siyu He, Lunzhi Dai et al. · 2023 · MedComm
  80. Iron-Mediated Overexpression of Amyloid Precursor Protein via Iron Responsive mRNA in Alzheimer’s Disease
    Mateen A. Khan · 2025 · International Journal of Molecular Sciences
  81. Microstructural changes in prodromal dementia with Lewy bodies compared to normal ageing: Multiparametric quantitative MRI evidences
    Eléna Chabran, Mary Mondino, Vincent Noblet, Laëtitia Degiorgis, Paulo Loureiro de Sousa, Frédéric Blanc · 2021 · European Journal of Neuroscience
  82. TRIMming the tangles
    Peng Lei, Scott Ayton · 2023 · 中国科学通报：英文版
  83. Abnormal Function of Metalloproteins Underlies Most Neurodegenerative Diseases
    Katja M. Kanninen, Anthony Robert White · 2017 · Elsevier eBooks
  84. The TAU isoform 1N4R restores vulnerability of MAPT knockout human iPSC-derived neurons to Amyloid beta-induced neuronal dysfunction
    Sarah Buchholz, Michael J. Bell, Mhd. Aghyad Al Kabbani, Lena Kluge, Cagla Cagkmak, Jennifer Klimek, Hans Zempel · 2022 · Research Square
  85. Reward motivation and cognitive flexibility in tau null-mutation mice
    Sara Oberrauch, Jeremy A. Metha, Maddison L. Brian, Samuel A. Barnes, Travis J. Featherby, Andrew John Lawrence, Daniël Hoyer, Carsten Murawski, Laura H. Jacobson · 2020 · Neurobiology of Aging
  86. Global Research Trends and Hotspots for Ferroptosis, Necroptosis, and Pyroptosis in Alzheimer’s Disease from the Past to 2023: A Combined Bibliometric Review
    Jianishaya Yeerlan, Binhong He, Xianliang Hu, Lushun Zhang · 2024 · Journal of Alzheimer s Disease Reports
  87. Iron and Alzheimer’s Disease
    Yi Liang Lo, Shihui Cheng · 2022 · Nutritional neurosciences
  88. Ferroptosis in Nervous System Diseases
    Jieru Wan, Xiuli Yang, Jian Wang · 2019 · Springer eBooks
  89. Frontotemporal dementia
    Eline Wauters, Kristel Sleegers, Marc Cruts, Christine Van Broeckhoven · 2017 · Elsevier eBooks
  90. Copper in Brain and Neurodegeneration
    Jeffrey R. Liddell, Ashley Ian Bush, Anthony Robert White · 2004 · Encyclopedia of Inorganic and Bioinorganic Chemistry
  91. Evidence of COMT dysfunction in the olfactory bulb in Parkinson’s disease
    Leah C. Beauchamp, Laura J. Ellett, Sydney M. A. Juan, Xiang M. Liu, Cameron J. Hunt, Clare L. Parish, Laura H. Jacobson, Claire E. Shepherd, Glenda Margaret Halliday, Ashley Ian Bush et al. · 2025 · Acta Neuropathologica
  92. Contributing Factors of Neurodegeneration in Alzheimer’s Disease
    Breeya A Tailor, Alexander R. Pilozzi, Xudong Huang · 2019 · Codon Publications eBooks
  93. Loss-of-function and gain-of-function studies refute the hypothesis that tau protein is causally involved in the pathogenesis of Huntington’s disease
    Isaline Mees, Shanshan Li, Leah C. Beauchamp, Kevin Jeffrey Barnham, Mathias Dutschmann, Anthony John Hannan, Thibault Renoir · 2022 · Human Molecular Genetics
  94. Effects of metals on extracellular vesicle signaling
    Shan Liu, Max Costa, Angélica Ortiz · 2022 · Elsevier eBooks
  95. Retracted Article: The interaction between insulin resistance and Alzheimer’s disease: a review article
    Nezar Y. Albar, H. Hassaballa, Hamza Shikh, Yassin Albar, Abdullatif Sheikh Ibrahim, Ahmed Hafez Mousa, Asim Muhammed Alshanberi, Ahmed Saber Elgebaly, Eshak I. Bahbah · 2024 · Postgraduate Medicine · Retracted
  96. Beclin 1 Complex and Neurodegenerative Disorders
    Ozaifa Kareem, Ghulam Nabi Bader, Faheem Hyder Pottoo, Mohd Amir, Md. Abul Barkat, Mukesh Pandey · 2020 · Advances in medical diagnosis, treatment, and care (AMDTC) book series
  97. Biomarker Modelling of Early Molecular Changes in Alzheimer’s Disease
    Ross W. Paterson, Jamie Toombs, Catherine F. Slattery, Jonathan M. Schott, Henrik Zetterberg · 2013 · Molecular Diagnosis & Therapy
  98. Excitoprotective effects of conditional tau reduction in excitatory neurons and in adulthood
    Yuliya Voskobiynyk, Zhiyong Li, J. Nicholas Cochran, M. Natalie Davis, Nancy V. N. Carullo, Rose B. Creed, Susan C. Buckingham, Alicia M. Hall, Scott M. Wilson, Erik D. Roberson · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  99. Metal‐dependent regulated cell death: Molecular architecture and translational frontiers
    Haoliang Hu, Zhe Chen, Yaqi Li, Jiayi Peng, Jiangang Cao, Hong Zhou, Mengqi Wang, Yuejia Du, H Wu, Huiqin Zhao et al. · 2026 · iMeta
  100. Alterations in iron levels in the locus coeruleus of a transgenic Alzheimer’s disease rat model
    Kayla Aishwarya Bhagaloo, Lei Yu, Elizabeth A. West, Daniel J. Chandler, Natalia Shcherbik · 2025 · Neuroscience Letters